Company profile: Tentamus Group
1.1 - Company Overview
Company description
- Provider of product safety and quality testing through a network of specialized laboratories. Services include analysis of food, water (particularly drinking water), feed, dietary supplements, pharmaceuticals, and agrosciences (fertilizers and crop protection). Capabilities span chemical, instrumental, physico-chemical, microbiological, molecular biological, and mechanical testing to ensure marketability and safety.
Products and services
- Pharmaceutical Testing: Performs chemical, physico-chemical, microbiological, and mechanical evaluations of pharmaceutical products across various global locations to assure quality and safety using specialized laboratories (global-scale)
- Food Testing: Conducts multi-method analyses in chemical, instrumental, microbiological, and molecular biological laboratories to verify marketability and safety of food products, leveraging a network of highly specialized facilities (multi-method)
- Water Testing: Conducts testing and analysis of water—particularly drinking water—to confirm safety and quality through a network of highly specialized laboratories focused on potable applications (drinking-water-specific)
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Tentamus Group
Catalent
HQ: United States
Website
- Description: Provider of advanced drug delivery technologies and outsourced development, manufacturing, and packaging services for the pharmaceutical, biotechnology, and consumer health industries worldwide. Includes Development & Clinical Services; Oral, Sterile, and Packaging technologies; ProteoSuite Oral; Softgel technologies; inhalation development & analytical; biologics development with GMP analytics; clinical supply services; consumer health products.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Catalent company profile →
Dark Horse Consulting
HQ: United States
Website
- Description: Provider of consulting services for cell and gene therapy development, including process codification and evaluation, development planning, analytical development for potency assays, buyer-side diligence, Phase III readiness reviews, comparability study design to demonstrate manufacturing equivalence, contract manufacturing management, facility design, and device development for manufacturing equipment.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Dark Horse Consulting company profile →
Calyx
HQ: United States
Website
- Description: Provider of medical imaging, eClinical, and regulatory solutions and services to solve complex challenges in clinical research.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Calyx company profile →
Inamed
HQ: Germany
Website
- Description: Provider of aerosol biophysics and technology with more than 30 years of experience.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Inamed company profile →
Noble Pharma
HQ: United States
Website
- Description: Provider of FDA-approved contract development and manufacturing services for extremely palatable animal health products, including formulation and process development; manufacturing of soft chews, creams, ointments, suspensions, tablets, powders, and pastes; clinical supplies; GLP analytical and ICH stability services; regulatory support; packaging with serialization and child-resistant options; and technology transfer and validation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Noble Pharma company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Tentamus Group
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Tentamus Group
2.2 - Growth funds investing in similar companies to Tentamus Group
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Tentamus Group
4.2 - Public trading comparable groups for Tentamus Group
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →